14 Results for "

PIM1-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "PIM1-IN-1" in MCE Product Catalog:

Cat. No.: HY-111552
CAS No.: 1417630-95-5
Purity:  99.83%
Target:  

Pim

Research Areas:  

Cancer

PIM1-IN-1 is a potent and highly selective PIM1/3 inhibitor, with IC50s of 7, 5530 and 70 nM for PIM1, PIM2, and PIM3, respectively, inhibits the phosphorylation of BAD, a downstream target of PIM, with an EC50 of 262 nM. PIM1-IN-1 shows no obvious effect on FLT3 or hERG binding. Antiproliferative and anti-cancer activity .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-10371
CAS No.: 1093222-27-5
Purity:  98.40%
Synonyms: LKB1/AAK1 dual INhibitor
Target:  

Pim

Research Areas:  

Cancer

Pim1/AAK1-IN-1 is a potent multi-kinase inhibitor with Kd values of 35 nM/53 nM/75 nM/380 nM for Pim1/AAK1/MST2/LKB1 respectively, and also inhibits MPSK1 and TNIK.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-18086
CAS No.: 491871-58-0
Synonyms: SC 204330
Target:  

Pim

Research Areas:  

Cancer

TCS PIM-1 1 (SC 204330) is a potent, selective and ATP-competitive Pim-1 kianse inhibitor with an IC50 of 50 nM, displays good selectivity over Pim-2 and MEK1/MEK2 (IC50s >20000 nM) .
loading...
    loading...
Cat. No.: HY-142696A
CAS No.: 2677026-15-0
Purity:  99.38%
Target:  

CDK Pim Apoptosis

Research Areas:  

Cancer

CDK6/PIM1-IN-1 (Compound 51) hydrochloride is an orally active and potent dual CDK6/PIM1 inhibitor with IC50 values of 39 and 88 nM, respectively. CDK6/PIM1-IN-1 hydrochloride inhibits CDK4 (IC50=3.6 nM). CDK6/PIM1-IN-1 hydrochloride significantly inhibits acute myeloid leukemia (AML) cell proliferation, arrest cell cycle at the G1 phase, and promote cell apoptosis. CDK6/PIM1-IN-1 exhibits potent anti-AML activity .
loading...
    loading...
Cat. No.: HY-142696
CAS No.: 2677026-14-9
Target:  

CDK Pim Apoptosis

Research Areas:  

Cancer

CDK6/PIM1-IN-1 is a potent and balanced dual CDK6/PIM1 inhibitor with IC50 values of 39 and 88 nM, respectively. CDK6/PIM1-IN-1 inhibits CDK4 (IC50=3.6 nM). CDK6/PIM1-IN-1 significantly inhibits acute myeloid leukemia (AML) cell proliferation, arrest cell cycle at the G1 phase, and promote cell apoptosis. CDK6/PIM1-IN-1 exhibits potent anti-AML activity .
loading...
    loading...
Cat. No.: HY-111552R
CAS No.: 1417630-95-5
Target:  

Reference Standards Pim

Research Areas:  

Cancer

PIM1-IN-1 (Standard) is the analytical standard of PIM1-IN-1 (HY-111552). This product is intended for research and analytical applications. PIM1-IN-1 is a potent and highly selective PIM1/3 inhibitor, with IC50s of 7, 5530 and 70 nM for PIM1, PIM2, and PIM3, respectively, inhibits the phosphorylation of BAD, a downstream target of PIM, with an EC50 of 262 nM. PIM1-IN-1 shows no obvious effect on FLT3 or hERG binding. Antiproliferative and anti-cancer activity .
loading...
    loading...
Cat. No.: HY-143898
CAS No.: 2762767-48-4
Target:  

Pim

Research Areas:  

Cancer

PIM1-IN-4 (Compound 8) is a potent inhibitor of PIM1. PIM1-IN-4 reveals strong inhibition of five other enzymes, i.e., SGK-1, PKA, CaMK-1, GSK3β, and MSK1. PIM1-IN-4 has the potential for the research of cancer diseases .
loading...
    loading...
Cat. No.: HY-173224
Target:  

CDK Pim

Research Areas:  

Cancer

CDK2/PIM1-IN-1 is an inhibitor of CDK2 (IC50: 0.27 μM) and PIM1 (IC50: 0.67 μM) kinases. CDK2/PIM1-IN-1 induces apoptosis and reduces tumor-promoting TNF-α expression. CDK2/PIM1-IN-1 has antitumor activity .
loading...
    loading...
Cat. No.: HY-135816
CAS No.: 292640-28-9
Target:  

Casein Kinase Pim

Research Areas:  

Inflammation/Immunology Cancer

CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders .
loading...
    loading...
Cat. No.: HY-143233
CAS No.: 2897622-19-2
Target:  

Pim HDAC Apoptosis

Research Areas:  

Cancer

PIM-1/HDAC-IN-1 (compound 4d) is a PIM-1 inhibitor, with an IC50 of 343.87 nM. PIM-1/HDAC-IN-1 has strong inhibitory activity and selectivity against HDAC 1 and HDAC 6, with IC50 values of 63.65 and 62.39 nM, respectively. PIM-1/HDAC-IN-1 exhibits apoptosis inducing potential in MCF-7 cell lines. PIM-1/HDAC-IN-1 shows pre-G1 apoptosis and cell cycle arrest at G2/M phase .
loading...
    loading...
Cat. No.: HY-P1404
CAS No.: 2305815-72-7
Target:  

Pim

Research Areas:  

Cancer

R8-T198wt is a cell-permeable carboxyl-terminal p27 Kip1 peptide exhibits anti-tumor activity by inhibiting Pim-1 kinase .
loading...
    loading...
Cat. No.: HY-143897
CAS No.: 2762767-56-4
Target:  

Pim Apoptosis

Research Areas:  

Cancer

PIM1-IN-3 (Compound HL8) is a potent inhibitor of PIM1. PIM1-IN-3 shows selective inhibition for the PIM-1 enzyme. PIM1-IN-3 induces apoptosis efficiently in Colo320 cells. PIM1-IN-3 has the potential for the research of cancer diseases .
loading...
    loading...
Cat. No.: HY-117744
CAS No.: 1482518-95-5
Target:  

Pim

Research Areas:  

Endocrinology Cancer

NMS-P645 is a PIM1 inhibitor. NMS-P645 exhibits anti-proliferative activity when combined with GDC-0941 (HY-50094) in TMPRSS2/ERG positive and negative PCa cells. NMS-P645 can reverse PIM1-induced pro-survival signals in prostate cells. NMS-P645 can be studied in research on prostate cancer .
loading...
    loading...
Cat. No.: HY-10371R
CAS No.: 1093222-27-5
Synonyms: LKB1/AAK1 dual INhibitor (Standard)
Target:  

Reference Standards Pim

Research Areas:  

Cancer

Pim1/AKK1-IN-1 (Standard) is the analytical standard of Pim1/AKK1-IN-1 (HY-10371). This product is intended for research and analytical applications. Pim1/AKK1-IN-1 is a potent multi-kinase inhibitor with Kd values of 35 nM/53 nM/75 nM/380 nM for Pim1/AKK1/MST2/LKB1 respectively, and also inhibits MPSK1 and TNIK.
loading...
    loading...
  • 1